background
middl
east
respiratori
syndrom
coronaviru
merscov
newli
recogn
zoonot
coronaviru
current
evid
confirm
role
dromedari
primari
human
infect
explain
sporad
commun
case
howev
asymptomat
subclin
case
could
repres
possibl
sourc
infect
commun
method
archiv
human
sera
collect
healthi
adult
blood
donor
differ
nation
western
part
saudi
arabia
obtain
merscov
seropreval
investig
sampl
test
merscov
antibodi
ab
elisa
confirm
test
neutral
ab
nab
use
pseudotyp
live
viru
neutral
assay
result
sampl
sera
individu
differ
nation
elisa
posit
ci
presenc
nab
confirm
sampl
ci
one
sampl
exhibit
posit
neutral
assay
confirm
seroposit
identifi
young
year
men
women
saudi
arabia
egypt
yemen
pakistan
palestin
sudan
india
without
signific
prefer
conclus
increas
trend
merscov
seropreval
observ
gener
popul
western
saudi
arabia
suggest
asymptomat
mild
infect
might
exist
act
unrecogn
sourc
infect
seroposit
individu
differ
nation
underscor
potenti
mer
export
outsid
arabian
peninsula
thu
enhanc
continu
surveil
highli
warrant
yate
correct
twotail
chi
test
fisher
exact
test
midp
exact
confid
limit
cl
calcul
use
openepi
open
middl
east
respiratori
syndrom
mer
emerg
respiratori
infect
associ
global
public
health
concern
caus
novel
lineag
c
beta
coronaviru
first
emerg
arabian
peninsula
typic
mer
symptom
includ
fever
myalgia
cough
chest
pain
short
breath
pneumonia
gastrointestin
symptom
multipl
organ
failur
mof
death
frequent
sever
case
especi
elderli
patient
comorbid
nonetheless
mild
asymptomat
infect
clearli
uncommon
dromedari
saudi
arabia
sever
middl
eastern
african
countri
major
merscov
reservoir
studi
shown
seroposit
common
noncamelid
livestock
speci
sheep
goat
suggest
possibl
role
anim
merscov
transmiss
especi
contact
infect
camel
studi
requir
confirm
find
therefor
current
epidemiolog
data
highli
suggest
infect
camel
could
main
sourc
primari
zoonot
human
case
howev
mani
sporad
presum
primari
case
report
contact
exposur
histori
camel
thu
clear
epidemiolog
link
transmiss
wellestablish
furthermor
despit
fact
secondari
case
due
humantohuman
spread
household
andor
healthcar
set
evid
sustain
humantohuman
transmiss
viru
seem
pass
easili
human
decemb
laboratoryconfirm
human
case
report
countri
mortal
howev
seem
overestim
true
mortal
rate
mild
asymptomat
mer
case
might
miss
routin
test
identifi
via
enhanc
molecular
serolog
immunolog
surveil
case
usual
common
among
camel
handler
well
household
individu
andor
healthcar
worker
contact
mer
patient
furthermor
earli
small
studi
report
serolog
evid
merscov
children
abattoir
worker
veterinarian
anim
handler
even
unexpos
individu
saudi
arabia
least
one
larg
crosssect
studi
reveal
seroposit
gener
saudi
popul
similarli
studi
qatar
show
gener
popul
seroposit
elisa
screen
blood
donor
howev
presenc
nab
confirm
one
blood
donor
interestingli
despit
high
preval
merscov
camel
differ
countri
kenya
nigeria
egypt
pakistan
confirm
evid
mer
case
among
human
limit
countri
except
two
seroposit
camel
handler
kenya
data
clearli
suggest
unknown
asymptomat
subclin
mer
infect
even
unrecogn
case
might
fact
exist
gener
popul
could
repres
underappreci
sourc
humantohuman
transmiss
therefor
essenti
conduct
continu
enhanc
surveil
epidemiolog
studi
determin
merscov
preval
especi
endem
region
sever
serolog
method
proven
valuabl
mer
epidemiolog
studi
screen
assay
elisa
immunofluoresc
confirm
neutral
assay
increas
specif
use
valid
recombin
combin
neutral
assay
investig
seropreval
rate
merscov
larg
cohort
archiv
sera
collect
healthi
blood
donor
differ
nation
resid
western
saudi
arabia
sampl
test
posit
use
confirm
merspseudotyp
live
viru
neutral
assay
case
posit
either
neutral
assay
consid
confirm
seroposit
mer
antibodi
ab
total
archiv
sera
collect
healthi
blood
donor
older
year
retriev
demograph
data
includ
sex
age
nation
obtain
ethic
approv
obtain
unit
biomed
ethic
king
abdulaziz
univers
hospit
start
studi
sampl
anonym
use
serial
number
african
green
monkey
kidneyderiv
vero
cell
atcc
cultur
maintain
complet
dulbecco
modifi
eagl
medium
dmem
human
isol
propag
titrat
vero
cell
tissu
cultur
infect
dose
tcid
assay
recombin
link
immunosorb
assay
inhous
indirect
merscov
subunit
protein
base
elisa
use
initi
screen
merscov
ab
serum
sampl
previous
describ
brief
dilut
serum
sampl
incub
block
flat
bottom
microtit
plate
thermo
scientif
rochest
ny
coat
gml
recombin
merscov
protein
sinobiolog
china
h
room
temperatur
subsequ
dilut
peroxidaseconjug
sheep
antihuman
igg
ab
amersham
ecl
pittsburgh
pa
ad
colorimetr
reaction
develop
use
tetramethylbenzidin
tmb
substrat
tmb
bluestop
solut
kpl
gaithersburg
md
use
stop
reaction
absorb
read
nm
sampl
test
duplic
sampl
optic
densiti
od
cutoff
valu
consid
posit
previous
describ
cutoff
valu
predetermin
averag
od
valu
known
neg
serum
sampl
standard
deviat
sd
show
sensit
specif
previous
describ
mer
pseudotyp
neutral
test
ppnt
perform
describ
previous
minor
modif
heatinactiv
serum
sampl
dilut
coincub
standard
amount
mer
pseudotyp
viral
particl
rlu
presenc
cell
cell
per
well
plate
incub
h
c
cell
cell
mer
pseudotyp
merspp
viral
particl
serum
includ
quadrupl
control
test
plate
cell
lyse
luciferas
activ
measur
use
brightglo
tm
luciferas
assay
system
promega
madison
wi
accord
manufactur
instruct
sampl
test
duplic
two
independ
experi
sampl
consid
posit
ppnt
titer
upon
reduct
luciferas
activ
well
two
experi
compar
cell
merspp
viral
particl
control
live
viru
microneutr
assay
perform
previous
describ
briefli
serial
dilut
heatinactiv
posit
serum
sampl
coincub
equal
dmem
volum
contain
tcid
merscov
test
quadrupl
determin
highest
dilut
inhibit
cytopath
effect
cpe
confluent
vero
cell
viru
control
cell
control
alway
includ
plate
neutral
ab
nab
titer
express
reciproc
highest
dilut
serum
sampl
complet
prevent
cpe
well
mn
titer
dilut
consid
posit
sampl
test
twice
independ
tabl
confirm
mer
seroposit
sampl
subject
ppnt
mnt
assay
sampl
posit
either
test
consid
confirm
posit
posit
sera
ie
specimen
tabl
confirm
posit
sampl
obtain
one
sampl
posit
ppnt
mnt
assay
mnt
titer
tabl
notabl
test
larg
number
neg
sampl
confirmatori
assay
show
fals
neg
result
confirm
valid
inhous
develop
indirect
sensit
even
higher
specif
compar
previou
report
case
confirm
individu
age
year
highest
rate
age
group
howev
statist
differ
group
tabl
base
confirm
case
signific
differ
observ
men
women
use
fisher
exact
test
furthermor
confirm
seroposit
identifi
individu
saudi
arabia
egypt
yemen
pakistan
palestin
sudan
india
without
signific
prefer
tabl
proport
confirm
infect
case
higher
studi
tabl
seropreval
merscov
blood
donor
base
year
collect
tabl
seropreval
merscov
blood
donor
base
age
group
compar
previous
report
rate
cohort
western
region
saudi
arabia
nationwid
studi
observ
statist
differ
examin
cohort
tabl
data
summari
posit
case
shown
supplementari
data
merscov
reminisc
sever
acut
respiratori
syndromecoronaviru
sarscov
emerg
thu
potenti
spread
global
seen
south
korea
sever
epidemiolog
studi
proven
merscov
endem
dromedari
close
contact
human
arabian
peninsula
africa
contact
merscov
shed
camel
could
main
caus
primari
case
arabian
peninsula
transmiss
explain
laboratori
confirm
infect
human
thu
propos
asymptomat
mild
case
gener
popul
could
act
unrecogn
sourc
infect
endem
region
nonetheless
limit
number
report
investig
merscov
seropreval
gener
popul
especi
endem
region
therefor
activ
enhanc
surveil
pivot
order
better
understand
true
burden
merscov
present
studi
investig
merscov
seropreval
archiv
human
sera
collect
western
region
saudi
arabia
sampl
collect
healthi
individu
differ
nation
donat
blood
major
tertiari
hospit
data
show
evid
merscov
bind
ab
test
cohort
seropreval
increas
year
interestingli
bind
ab
detect
individu
differ
countri
suggest
individu
could
respons
merscov
export
outsid
arabian
peninsula
consist
previou
report
nab
confirm
posit
serum
sampl
obtain
mostli
saudi
men
result
confirm
seropreval
gener
popul
western
region
saudi
arabia
confirm
seropreval
higher
previous
report
rate
gener
saudi
popul
well
popul
western
region
countri
although
statist
signific
observ
two
studi
import
note
possibl
asymptomat
mild
infect
remain
nonconfirm
individu
overlook
mostli
high
specif
ppnt
mnt
assay
could
result
reduc
sensit
test
algorithm
well
high
sensit
least
sensit
could
actual
detect
nonneutr
ab
furthermor
crossreact
lowaffin
igg
coronavirus
complet
exclud
elisa
merscov
low
homolog
crossreact
subunit
known
coronavirus
thu
could
postul
young
healthi
individu
age
year
might
inde
expos
merscov
suffer
subclin
infect
mount
transient
weak
nab
respons
might
wane
quickli
result
fals
neg
result
neutral
assay
partial
true
recent
demonstr
individu
histori
mer
infect
includ
highrisk
group
could
elicit
detect
nab
anoth
possibl
antigen
divers
merscov
strain
circul
thu
bind
ab
crossneutr
therefor
prospect
seroepidemiolog
studi
combin
serolog
immunolog
method
order
determin
actual
diseas
burden
caus
asymptomat
subclin
case
act
unidentifi
intermedi
sourc
viru
transmiss
popul
simpl
comparison
previous
publish
nationwid
seropreval
studi
saudi
arabia
clear
seropreval
ab
cohort
current
studi
ci
compar
report
et
al
cohort
collect
region
ci
nab
detect
report
nonetheless
observ
higher
overal
rate
confirm
seroposit
ci
compar
previous
report
nationwid
seropreval
rate
ci
case
seem
increas
year
similarli
extrapol
result
also
indic
could
around
seroposit
individu
total
popul
western
region
alon
number
huge
concern
especi
region
host
one
largest
mass
gather
event
hajj
umrah
continu
travel
peopl
movement
livestock
western
part
saudi
arabia
could
repres
possibl
way
merscov
infect
export
humantohuman
zoonot
transmiss
screen
serum
sampl
collect
healthi
blood
donor
differ
nation
resid
western
saudi
arabia
show
increas
seroposit
rate
young
healthi
individu
age
year
differ
countri
aad
laboratori
test
analyz
data
gener
figur
ssa
amhass
mm
laboratori
test
coordin
sampl
collect
data
retriev
aa
laboratori
test
sa
rya
search
publish
work
aam
analyz
data
sih
arrang
sampl
collect
data
retriev
nka
laboratori
test
analyz
data
eia
organ
supervis
sampl
logist
studi
amhash
design
coordin
studi
search
publish
work
wrote
manuscript
analyz
data
gener
figur
author
revis
approv
final
version
manuscript
none
declar
sponsor
role
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
final
respons
decis
submit
public
